Our site uses cookies

I agree Our site saves small pieces of text information, called “cookies” on your device. Find out more in our cookie policy. You can disable the usage of cookies by changing the settings of your browser. By continuing to browse the site you are agreeing to our use of cookies.

M&A and early interventions

M&A procurement: How early engagement can help post-merger transition

We look at how early engagement with procurement teams can help smooth the post-merger transition.

M&A synergy savings

M&A procurement: How to achieve synergy savings post-merger

After a merger or acquisition all eyes are on procurement to deliver short and long-term cost savings. So how do you turn M&A promises into action?

Highly engineered products

How to negotiate highly engineered manufacturing products

Sourcing thousands of highly engineered components across the globe with high material and labour content, and high supplier change barriers is a huge challenge

Financial services procurement

Is procurement behind the new wave of innovation in banking?

Three procurement leaders talk us through the current trends in financial services procurement

Case study

Transforming procurement for a global manufacturer

Challenging market conditions drive down revenue and profits, our client needed to boost their bottom line and deliver a better return to private equity investors.

Procurement strategy

10 steps to procurement excellence

The 10 stages that helped media business KNect365 take its procurement performance from ‘basic’ to world-class

Procurement savings
Case study

KNect365: building a best-in-class Procurement function

How Knect365's new Procurement function signed off £5.8m in annualised savings in just six months

Image of GlaxoSmithkline CPO Jean-Yves Rotté-Geoffroy

Global procurement means local too: GlaxoSmithKline CPO

Overcoming legacy structures and understanding local needs is vital for the success of Procurement says GlaxoSmithKline’s CPO.


How GlaxoSmithKline reshaped its procurement categories

GlaxoSmithKline’s CPO explains how the firm boosted business engagement, maximised supplier value and overcame structural obstacles.